We are live on
!
Find out more
DP
Dundas Partners Portfolio holdings
AUM
$1.25B
1-Year Est. Return
13.92%
This Fund
S&P 500
This Quarter
Est. Return
+12.62%
1 Year Est. Return
+13.92%
3 Year Est. Return
+60.92%
5 Year Est. Return
+73.49%
10 Year Est. Return
–
AUM
$805M
AUM Growth
+$95.8M
(+14%)
Cap. Flow
+$87.5M
Cap. Flow
% of AUM
10.88%
Top 10 Holdings %
Top 10 Hldgs %
37.53%
Holding
59
New
3
Increased
37
Reduced
1
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$22.4M |
| 2 |
Equifax
EFX
|
+$20.8M |
| 3 |
Nordson
NDSN
|
+$20.4M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$10.6M |
| 5 |
Amphenol
APH
|
+$8.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.7M |
| 2 |
Waste Management
WM
|
+$8.14M |
| 3 |
Zoetis
ZTS
|
+$4.18M |
| 4 |
Jackson Financial
JXN
|
+$447K |
| 5 |
MIME
Mimecast Limited
MIME
|
+$4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.65% |
| 2 | Financials | 18.2% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 7.83% |
| 5 | Consumer Discretionary | 6.48% |
Similar funds
TCA
PIA
DAM
HP
CPA
TCA
LIA
TBC
Dundas Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Dundas Partners held 59 positions worth $805M, up 14% from $709M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Dundas Partners deployed $87.5M of net new capital in Q4 2021, opening 3 new positions and adding to 37 existing holdings. Its largest new stake was Brown & Brown: 346,617 shares worth $23.6M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 41% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Zoetis, an estimated $4.18M trimmed.
- Dundas Partners's largest Q4 2021 buy was Brown & Brown: 346,617 shares worth $23.6M.
- Dundas Partners added most to Activision Blizzard in Q4 2021, an estimated $10.6M increase.
- Dundas Partners's biggest Q4 2021 reduction was Zoetis, cutting an estimated $4.18M.
- Dundas Partners fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.7M.
- Dundas Partners's ten largest holdings make up 38% of its $805M portfolio in Q4 2021.
- Dundas Partners opened 3 new positions and closed 4 in Q4 2021.
- Dundas Partners's portfolio value rose 14% quarter-over-quarter to $805M.
Based on Dundas Partners's 13F filing for Q4 2021, filed 14 Feb 2022.